Kim Nichol
About
Kim Nichol is a scholar working on Epidemiology, Molecular Medicine and Infectious Diseases.
According to data from OpenAlex, Kim Nichol has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 18 papers in Molecular Medicine and 14 papers in Infectious Diseases. Recurrent topics in Kim Nichol's work include Antibiotic Resistance in Bacteria (18 papers), Pneumonia and Respiratory Infections (12 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). Kim Nichol is often cited by papers focused on Antibiotic Resistance in Bacteria (18 papers), Pneumonia and Respiratory Infections (12 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). Kim Nichol collaborates with scholars based in Canada, United States and Kenya. Kim Nichol's co-authors include George G. Zhanel, Daryl J. Hoban, James A. Karlowsky, Aleksandra Wierzbowski, Ayman Noreddin, Michael R. Mulvey, Megan Menard, Michael A. Kuskowski, Brian Johnston and James R. Johnson and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
In The Last Decade
Kim Nichol
31 papers receiving 1.4k citations
Peers
Kim Nichol
S. Bouchillon United States
Michael Kresken Germany
Melanie Baxter Canada
Iciar Rodríguez-Avial Spain
Glen Hansen United States
Flávia Rossi Brazil
Kimberly A. Nichol Canada
Cristina Pitart Spain
Vered Schechner Israel
Nancy M. Laing Canada
Citations per year, relative to Kim Nichol Kim Nichol (= 1×)
peers
S. Bouchillon
Countries citing papers authored by Kim Nichol
Since
Specialization
Citations
This map shows the geographic impact of Kim Nichol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Nichol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Nichol more than expected).
Fields of papers citing papers by Kim Nichol
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kim Nichol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Nichol. The network helps show where Kim Nichol may publish in the future.
Co-authorship network of co-authors of Kim Nichol
This figure shows the co-authorship network connecting the top 25 collaborators of Kim Nichol. A scholar is included among the top collaborators of Kim Nichol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Nichol. Kim Nichol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Dust, Kerry, Adam Hedley, Kim Nichol, et al.. (2020). Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2. Journal of Virological Methods. 285. 113970–113970.
2.
Karlowsky, James A., Heather J. Adam, Melanie Baxter, et al.. (2018). PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium icile Surveillance Study (CAN-DIFF) 2013–2015. Diagnostic Microbiology and Infectious Disease. 91(2). 105–111.
3.
Karlowsky, James A., Kim Nichol, & George G. Zhanel. (2015). Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance. Clinical Infectious Diseases. 61(suppl 2). S58–S68.
4.
Walkty, Andrew, John M. Embil, Kim Nichol, & James A. Karlowsky. (2014). An Unusual Case of Streptococcus anginosus Group Pyomyositis Diagnosed Using Direct 16S Ribosomal DNA Sequencing. Canadian Journal of Infectious Diseases and Medical Microbiology. 25(1). 32–34.
5.
Alsaedi, Asim, Jann‐Tay Wang, Kim Nichol, et al.. (2014). Hypermucoviscous Klebsiella Syndrome Without Liver Abscess in a Patient With Immunoglobulin G2 Immune Deficiency. Open Forum Infectious Diseases. 1(2). ofu080–ofu080.
6.
Bridger, Natalie, Andrew Walkty, Maryanne Crockett, et al.. (2012). Caulobacter Species as a Cause of Postneurosurgical Bacterial Meningitis in a Pediatric Patient. Canadian Journal of Infectious Diseases and Medical Microbiology. 23(1). e10–2.
7.
Johnson, James R., Megan Menard, Brian Johnston, et al.. (2009). Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004. Antimicrobial Agents and Chemotherapy. 53(7). 2733–2739.
8.
Zhanel, George G., Mel DeCorby, Kim Nichol, et al.. (2009). Antimicrobial Susceptibility of 6685 Organisms Isolated from Canadian Hospitals: CANWARD 2007. Canadian Journal of Infectious Diseases and Medical Microbiology. 20(A).
9.
Zhanel, George G., James A. Karlowsky, Mel DeCorby, et al.. (2009). Prevalence of Antimicrobial‐Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2007). Canadian Journal of Infectious Diseases and Medical Microbiology. 20(A).
10.
Baudry, Patricia J., Kim Nichol, Melanie DeCorby, et al.. (2009). Mechanisms of resistance and mobility among multidrug-resistant CTX-M–producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America. Diagnostic Microbiology and Infectious Disease. 63(3). 319–326.
11.
Nichol, Kim. (2008). Activity of Telavancin Against Gram-Positive Cocci Isolated from Canadian Hospitals: CANWARD 2007. 46th Annual Meeting.
12.
Zhanel, George G., Mel DeCorby, Kim Nichol, et al.. (2008). Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Diagnostic Microbiology and Infectious Disease. 62(1). 67–80.
13.
Zhanel, George G., Mel DeCorby, Kim Nichol, et al.. (2008). Characterization of Methicillin‐Resistant Staphylococcus aureus, Vancomycin‐Resistant Enterococci and Extended‐Spectrum Beta‐Lactamase‐Producing Escherichia coli in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (Can‐Icu) Study (2005–2006). Canadian Journal of Infectious Diseases and Medical Microbiology. 19(3). 243–249.
14.
Karlowsky, James A., et al.. (2007). Genetic relatedness of multidrug-resistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimens. Diagnostic Microbiology and Infectious Disease. 58(3). 283–287.
15.
Zhanel, George G., Xi Wang, Kim Nichol, et al.. (2006). Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998–2004. International Journal of Antimicrobial Agents. 28(5). 465–471.
16.
Lagacé‐Wiens, Philippe, Kim Nichol, Lindsay E. Nicolle, et al.. (2006). ESBL Genotypes in Fluoroquinolone‐Resistant and Fluoroquinolone‐Susceptible ESBL‐Producing Escherichia coli Urinary Isolates in Manitoba. Canadian Journal of Infectious Diseases and Medical Microbiology. 18(2). 133–137.
17.
Zhanel, George G., Tamiko Hisanaga, Nancy M. Laing, et al.. (2005). Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). International Journal of Antimicrobial Agents. 26(5). 380–388.
18.
Zhanel, George G., Kim Nichol, Ayman Noreddin, et al.. (2004). The Glycylcyclines. Drugs. 64(1). 63–88.
19.
Zhanel, George G., Tamiko Hisanaga, Kim Nichol, Aleksandra Wierzbowski, & Daryl J. Hoban. (2003). Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae. Expert Opinion on Emerging Drugs. 8(2). 297–321.
20.
Zhanel, George G., Andrew Walkty, Kim Nichol, et al.. (2003). Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada. Diagnostic Microbiology and Infectious Disease. 45(1). 63–67.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by S. Bouchillon Breakdown of academic impact, for papers by Michael Kresken Breakdown of academic impact, for papers by Melanie Baxter Breakdown of academic impact, for papers by Iciar Rodríguez-Avial Breakdown of academic impact, for papers by Glen Hansen Breakdown of academic impact, for papers by Flávia Rossi Breakdown of academic impact, for papers by Kimberly A. Nichol Breakdown of academic impact, for papers by Cristina Pitart Breakdown of academic impact, for papers by Vered Schechner Breakdown of academic impact, for papers by Nancy M. Laing